Patients should be extremely cautious of any websites, social media advertisements, or online retailers claiming to sell GLP-1 patches
So, if someone with the characteristics of this treatment group takes semaglutide 2.4mg on the standard 16 week titration schedule, they can expect a (geometric) average reduction of 48.6% The way the researchers are interpreting their findings is that the average reduction in uACR is -48.6% BUT if the placebo group is a correct representation of doing nothing (and they did nothing) they could have expected their uACR to go up 7.4% over those same 24 weeks, so in theory they end up 52.1% better off based on the geometric mean
Members can join small, coach-led groupsincluding those focused on GLP-1 use, menopause, nutrition, or movement to learn from others on a similar path and feel truly supported
It is based on the different product
Use Telehealth Services: Many online platforms, such as Ro and Sesame, offer virtual consultations to evaluate eligibility